Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation: A novel approach to atherosclerosis therapy
Toll-like receptor 3 (TLR3), as an important pattern recognition receptor (PRR), dominates the innate and adaptive immunity regulating many acute and chronic inflammatory diseases. Atherosclerosis is proved as an inflammatory disease, and inflammatory events involved in the entire process of initiat...
Main Authors: | Xiaohong Cen, Baoqu Wang, Yuqing Liang, Yanlin Chen, Yu Xiao, Shaohua Du, Kutty Selva Nandakumar, Hang Yin, Shuwen Liu, Kui Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383522002672 |
Similar Items
-
THE ROLE OF TOLL-LIKE RECEPTORS POLYMORPHISM IN ATHEROSCLEROSIS COMPLICATIONS DEVELOPMENT
by: O. L. Barbarash, et al.
Published: (2015-12-01) -
The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
by: Xiaohong Cen, et al.
Published: (2018-08-01) -
The role of polymorphisms within genes encoding Toll-like receptors in coronary atherosclerosis
by: A. V. Ponasenko, et al.
Published: (2015-09-01) -
GENOMIC FACTORS (TOLL-LIKE RECEPTORS GENES) IN DEVELOPMENT OF ATHEROSCLEROSIS AND ITS CLINICAL MANIFESTATIONS
by: I. I. Zhidkova, et al.
Published: (2017-07-01) -
Toll roads and bridges
Published: (1981)